PEOPLE - CytoCore makes appointment:
This article was originally published in Clinica
Executive Summary
Augusto Ocana has been appointed CEO for US cancer screening systems company CytoCore (Chicago, Illinois), succeeding Dr David Weissberg. On the eve of the international launch of its new product, the e2Collector (Pap smear device), the company will leverage Dr Ocana's expertise in market distribution, strategic partnering, financing and business development. Previous positions held by Dr Ocana include senior vice-president and managing director at CH-Werfen (Barcelona), a healthcare group that manufactures and distributes diagnostics, medical devices and scientific instruments.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.